Each filer's latest filing for 92025Y103 since 12/18/2024, largest first.
| Filer | % of Class | Filed | ||
|---|---|---|---|---|
|
Bpifrance Participations SA
13D/A
|
9.3% |
5/12/2026
Event 5/5/2026
|
||
| Bpifrance Participations S.A. | 7.0% | |||
| EPIC Bpifrance | 7.0% | |||
| Bpifrance S.A. | 7.0% | |||
| Caisse des depots et consignations | 9.3% | |||
| CDC Croissance S.A. | 2.3% | |||
| Under 5%, checked the "5 percent or less" box, or amended by a later filing (1) | ||||
|
Frazier Life Sciences Public Fund, L.P.
13G
|
3.6% |
5/12/2026
Event 5/5/2026
|
||
| Frazier Life Sciences Public Fund, L.P. | 3.6% | |||
| FHMLSP, L.P. | 3.6% | |||
| FHMLSP, L.L.C. | 3.6% | |||
| Frazier Life Sciences X, L.P. | 0.1% | |||
| FHMLS X, L.P. | 0.1% | |||
| FHMLS X, L.L.C. | 0.1% | |||
| Frazier Life Sciences XI, L.P. | 0.2% | |||
| FHMLS XI, L.P. | 0.2% | |||
| FHMLS XI, L.L.C. | 0.2% | |||
| Frazier Life Sciences XII, L.P. | 0.5% | |||
| FHMLS XII, L.P. | 0.5% | |||
| FHMLS XII, L.L.C. | 0.5% | |||
| James N. Topper | 0.1% | |||
| Patrick J. Heron | 0.1% | |||
| Period | Filers | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2026 Q3 | 5 | 359 k | $2.22M |
| 2026 Q2 | 20 | 3.78 M | $19.8M |
| 2026 Q1 | 21 | 3.91 M | $24.4M |
| 2025 Q4 | 19 | 5.20 M | $45.8M |
| 2025 Q3 | 18 | 5.28 M | $64.5M |
| 2025 Q2 | 19 | 4.52 M | $25.6M |
| 2025 Q1 | 15 | 674 k | $4.53M |
| 2024 Q4 | 13 | 719 k | $3.16M |
| 2024 Q3 | 11 | 718 k | $4.35M |
| 2024 Q2 | 12 | 655 k | $4.75M |
| 2024 Q1 | 12 | 462 k | $3.69M |
| 2023 Q4 | 10 | 391 k | $4.03M |
| 2023 Q3 | 11 | 397 k | $4.69M |
| 2023 Q2 | 12 | 378 k | $5.55M |
| 2023 Q1 | 12 | 414 k | $4.27M |
| 2022 Q4 | 11 | 403 k | $5.16M |
| 2022 Q3 | 12 | 434 k | $4.36M |
| 2022 Q2 | 10 | 61.9 k | $1.40M |
| 2022 Q1 | 12 | 138 k | $4.70M |
| 2021 Q4 | 11 | 115 k | $6.43M |
| 2021 Q3 | 9 | 263 k | $8.27M |
| 2021 Q2 | 10 | 801 k | $21.1M |